Generate a tailored SOP for Dr. Aleman Aleman. Improve your application with a focused, well-structured draft.
Dr. Aleman serves as a co-director of the Center for Hereditary Retinal Degenerations at the University of Pennsylvania, focusing on clinical care for patients suffering from inherited retinal diseases, including retinitis pigmentosa and Leber congenital amaurosis. His work is pivotal in advancing both research and treatment options for these conditions. Alongside other co-directors, he leads world-class research initiatives and clinical trials aimed at improving therapeutic outcomes for patients experiencing progressive vision loss. Dr. Aleman has contributed to significant findings in gene augmentation therapy, demonstrating efficacy in restoring vision and mobility in patients through innovative treatment protocols. His recent publications highlight breakthroughs in retinal disease therapy, particularly the phase 1/2 clinical trial results for LCA5 gene therapy published in 2025.
Center for Hereditary Retinal Degenerations • Philadelphia, PA
Co-Director leading clinical care and research initiatives in hereditary retinal diseases.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.